Baker Hughes Secures Conditional EU Nod for Chart Deal, Divestiture May Trim Synergies

What happened

Baker Hughes has received conditional EU antitrust approval for its $13.6 billion acquisition of Chart Industries, after agreeing to sell a Chart business to address competition concerns. This milestone removes a key regulatory overhang, but the required divestiture may reduce the $325 million anticipated annual cost synergies or delay their realization. The deal remains subject to other regulatory approvals and financing, but the EU's conditional blessing supports a mid-2026 close timeline. The stock's recent rally to $56.88 already prices in a smooth integration, so the net impact is modestly positive but not a game-changer given the premium valuation. Investors should monitor the terms of the divestiture and any impact on synergy targets.

Implication

The conditional EU nod reduces execution risk but reinforces our view that the market discounts too rosy a scenario. Our base case of $55 assumes orderly integration with modest synergies; the divestiture could push synergies below $325 million, making the upside even more capped. We see potential return to $40-55 range if LNG orders slow or integration stumbles. Hold or trim positions, waiting for a better entry near $48 or clearer post-close evidence of de-leveraging.

Thesis delta

Regulatory approval is a positive step, but the conditional nature (divestiture) may narrow the synergy opportunity, slightly lowering our base case upside. Our 'Potential Sell' stance remains unchanged, as the stock at $56.88 already prices in a flawless outcome. The key risk now shifts from regulatory delay to integration execution and LNG order sustainability.